References
- Ishiura H, Fukuda Y, Mitsui J, Nakahara Y, Ahsan B, Takahashi Y, Ichikawa Y, Goto J, Sakai T, Tsuji S, et al. Posterior column ataxia with retinitis pigmentosa in a Japanese family with a novel mutation in FLVCR1. Neurogenetics. 2011;12(2):117–21.doi:10.1007/s10048-010-0271-4.
- Rajadhyaksha AM, Elemento O, Puffenberger EG, Schierberl KC, Xiang JZ, Putorti ML, Berciano J, Poulin C, Brais B, Michaelides M, et al. Mutations in FLVCR1 cause posterior column ataxia and retinitis pigmentosa. The American Journal of Human Genetics. 2010;87(5):643–54.doi:10.1016/j.ajhg.2010.10.013.
- Stenson PD, Mort M, Ball EV, Shaw K, Phillips A, Cooper DN.The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet. 2014;133(1):1–9.doi:10.1007/s00439-013-1358-4.
- Kircher M, Witten DM, Jain P, O’roak BJ, Cooper GM, Shendure J.A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46(3):310.doi:10.1038/ng.2892.
- Jagadeesh KA, Wenger AM, Berger MJ, Guturu H, Stenson PD, Cooper DN, Bernstein JA, Bejerano G. M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity. Nat Genet. 2016;48(12):1581–86.doi:10.1038/ng.3703.
- Yanatori I, Yasui Y, Miura K, Kishi F.Mutations of FLVCR1 in posterior column ataxia and retinitis pigmentosa result in the loss of heme export activity. Blood Cells Mol Dis. 2012;49(1):60–66.doi:10.1016/j.bcmd.2012.03.004.
- Puffenberger EG, Jinks RN, Sougnez C, Cibulskis K, Willert RA, Achilly NP, Cassidy RP, Fiorentini CJ, Heiken KF, Lawrence JJ, et al. Genetic mapping and exome sequencing identify variants associated with five novel diseases. PLoS One. 2012;7(1):e28936.doi:10.1371/journal.pone.0028936.
- Shaibani AWL-J, Wong L-J, Wei Zhang V, Lewis RA, Shinawi M. Autosomal recessive posterior column ataxia with retinitis pigmentosa caused by novel mutations in the FLVCR1 gene. Int J Neurosci. 2015;125(1):43–49.doi:10.3109/00207454.2014.904858.
- Glöckle N, Kohl S, Mohr J, Scheurenbrand T, Sprecher A, Weisschuh N, Bernd A, Rudolph G, Schubach M, Poloschek C, et al. Panel-based next generation sequencing as a reliable and efficient technique to detect mutations in unselected patients with retinal dystrophies. Eur J Human Genet. 2013;22(1):99–104.doi:10.1038/ejhg.2013.72.
- Tiwari A, Bahr A, Bahr L, Fleischhauer J, Zinkernagel MS, Winkler N, Barthelmes D, Berger L, Gerth-Kahlert C, Neidhardt J, et al. Next generation sequencing based identification of disease-associated mutations in Swiss patients with retinal dystrophies. Sci Rep. 2016;6:28755.
- Liu X, Xiao J, Huang H, Guan L, Zhao K, Xu Q, Zhang X, Pan X, Gu S, Chen Y, et al. Molecular genetic testing in clinical diagnostic assessments that demonstrate correlations in patients with autosomal recessive inherited retinal dystrophy. JAMA Ophthalmol. 2015;133(4):427–36.doi:10.1001/jamaophthalmol.2014.5831.
- Sergouniotis PI, Barton SJ, Waller S, Perveen R, Ellingford JM, Campbell C, Hall G, Gillespie RL, Bhaskar SS, Ramsden SC, et al. The role of small in-frame insertions/deletions in inherited eye disorders and how structural modelling can help estimate their pathogenicity. Orphanet J Rare Dis. 2016;11(1):125.doi:10.1186/s13023-016-0505-0.
- Khan AA, Quigley JG.Heme and FLVCR-related transporter families SLC48 and SLC49. Mol Aspects Med. 2013;34(2–3):669–82.doi:10.1016/j.mam.2012.07.013.
- Khan AA, Quigley JG.Control of intracellular heme levels: heme transporters and heme oxygenases. Biochim Biophys Acta. 2011;1813(5):668–82.doi:10.1016/j.bbamcr.2011.01.008.